{
  "kind": "framework",
  "value": "eroom-s-law",
  "collectionKey": "slides:framework:eroom-s-law:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 3,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
      "docSlug": "07da8690ded5d079d6760889d2f598d8",
      "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
      "authorId": "benevolentai",
      "authorName": "BenevolentAI",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly labeled in the chart title",
      "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/23",
      "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
      "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 23,
          "from": 23,
          "beatId": "d2ac2a00-8894-4e20-94e9-4fe7863b2d44",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The deck agitates the problem by highlighting the challenges in discovering and developing medicines",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-3cc2-7451-b551-f16094d96b35",
      "docSlug": "3309edf11a92b656dd98b92129b54a19",
      "documentTitle": "Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides",
      "authorId": "recursion-pharmaceuticals",
      "authorName": "Recursion Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "The chart uses a logarithmic scale on the y-axis to show the exponential decay of efficiency over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly labeled in the chart as the trend of declining drug discovery efficiency.",
      "slideHref": "/slides/019de074-3cc2-7451-b551-f16094d96b35/7",
      "deckHref": "/decks/019de074-3cc2-7451-b551-f16094d96b35",
      "deckAnchorHref": "/decks/019de074-3cc2-7451-b551-f16094d96b35#slide-7",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "de7d78e4-cf31-41e1-b19f-4472b43ac22b",
          "evidence": "The document highlights the costs of inefficient drug discovery methods, including the potential for missed opportunities and increased costs.",
          "position": 0,
          "objective": "What are the costs of not improving drug discovery efficiency?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 7,
          "beatId": "9ac4deea-fcfa-494a-88c8-0c7f9e8949f8",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the pain points in the biopharmaceutical industry, including declining efficiency in drug discovery.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de074-3cc2-7451-b551-f16094d96b35",
      "docSlug": "3309edf11a92b656dd98b92129b54a19",
      "documentTitle": "Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides",
      "authorId": "recursion-pharmaceuticals",
      "authorName": "Recursion Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide highlights the divergence between technological progress in computing and the stagnation in pharmaceutical R&D productivity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Explicitly labeled in the chart",
      "slideHref": "/slides/019de074-3cc2-7451-b551-f16094d96b35/8",
      "deckHref": "/decks/019de074-3cc2-7451-b551-f16094d96b35",
      "deckAnchorHref": "/decks/019de074-3cc2-7451-b551-f16094d96b35#slide-8",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "de7d78e4-cf31-41e1-b19f-4472b43ac22b",
          "evidence": "The document highlights the costs of inefficient drug discovery methods, including the potential for missed opportunities and increased costs.",
          "position": 0,
          "objective": "What are the costs of not improving drug discovery efficiency?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 7,
          "beatId": "9ac4deea-fcfa-494a-88c8-0c7f9e8949f8",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the pain points in the biopharmaceutical industry, including declining efficiency in drug discovery.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}